ORIC — ORIC Pharmaceuticals Inc.

Ownership history in Column Group LLC  ·  21 quarters on record

This page tracks every 13F SEC filing in which Column Group LLC reported a position in ORIC Pharmaceuticals Inc. (ORIC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
54.68% (2025 Q2)
Avg. % of fund
22.98%
First filed
2020 Q4
Last filed
2025 Q4
Quarters held
21
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 3,540,777 — 0% 34.98% $29.0M $8.18
2025 Q3 UNCHANGED 3,540,777 — 0% 52.48% $42.5M $12.00
2025 Q2 UNCHANGED 3,540,777 — 0% 54.68% $35.9M $10.15
2025 Q1 UNCHANGED 3,540,777 — 0% 44.67% $19.8M $5.58
17 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    ORIC price (monthly, adj. close)

Other funds also holding ORIC

As of 2025 Q4 — sorted by position size

PFIZER INC 18.6% SR ONE CAPITAL MANAGEMENT, LP 3Y 5.34% EcoR1 Capital, LLC 3Y 7Y 2.5% VR Adviser, LLC 3Y 2.29% Euclidean Capital LLC 3Y 2.19% First Turn Management, LLC 1.88% NEA Management Company, LLC 3Y 7Y 1.72% MPM BioImpact LLC 3Y 1.68% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 1.59% SILVERARC CAPITAL MANAGEMENT, LLC 3Y 1.27%
← Back to Column Group LLC Holdings